Consensus Health's Arnold Pallay, MD FAAFP Selected as a 2025 Healthcare Hero By Njbiz Magazine

June 3, 2025 8:20 AM

Consensus Health, a leading New Jersey-based healthcare organization with a physician-led medical group and an Independent Physician Alliance (IPA), announced today Arnold Pallay, MD FAAFP, practicing physician and medical director, was named a 2025 Healthcare Hero by NJBIZ Magazine, a leading business journal covering New Jersey.The Healthcare Heroes Awards program was created to recognize excellence, promote innovation and honor the efforts of...

Read more

Avel eCare Positions Technology as a Lifeline for Hospital Viability and Patient Care

June 3, 2025 8:12 AM

As hospital systems nationwide continue to grapple with staff shortages, rising costs, and the ever-pressing demand to improve patient outcomes, Avel eCare is redefining how technology can transform healthcare delivery. Through its innovative telemedicine solutions, including 24/7 ICU support, Avel eCare is helping hospitals increase their patient throughput, reduce costly transfers, and improve revenue cycle management-ultimately enabling more...

Read more

CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief

June 3, 2025 8:00 AM

CBD Life Sciences Inc. (OTC Pink:CBDL), a leader in the CBD wellness industry, proudly announces the launch of its groundbreaking line of CBD-infused vaginal and rectal suppositories. This innovative product is poised to transform the landscape of women's health by offering targeted relief for a myriad of conditions, including menstrual cramps, endometriosis, pelvic floor dysfunction, and gastrointestinal discomfort.A Breakthrough for Localized,...

Read more

Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter

June 3, 2025 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that Water Tower Research ("WTR") has published a report highlighting a significant milestone in the Company's AI Nose project for elderly care. AI Nose has reached approximately 85% accuracy in excretion odor detection-improving over the recently met internal milestone of 80%.Key Highlights from the Report:AI Nose...

Read more

INCREDABLE and SCOUTING AMERICA Redefine Credentialing at Scale

June 3, 2025 8:00 AM

As part of a broader effort to improve how it supports thousands of volunteers, Scouting America, the nation's foremost youth leadership and development organization, has partnered with Incredable, the industry's most configurable credentialing platform and a subsidiary of Intiva Health, to modernize how the organization manages volunteer credentials across national events.With a network of medical volunteers supporting programs across the...

Read more

DEA in Marijuana Crisis: Calls for Termination of Key Officials Amid Constitutional Defiance, Ethical Violations, and Marijuana Bias

June 3, 2025 5:00 AM

The Drug Enforcement Administration (DEA) stands accused of operating as a rogue agency, defying Supreme Court rulings, violating ethical standards, and engaging in selective enforcement of federal cannabis laws. With mounting legal challenges, bipartisan condemnation, and internal misconduct, pressure is building for mass terminations, structural reforms, and congressional intervention. 1. Ethical & Legal Failures: DEA Attorney Aarathi Haig's...

Read more

PoZibio(R) Named Finalist for 'Ingredient of the Year: Microbiome Modulation' at NutraIngredients-USA Awards

June 3, 2025 4:30 AM

Sabinsa, a global leader in health science, proudly announces that PoZibio®, an innovative postbiotic ingredient developed with Postbiotics, Inc., has been named a finalist for "Ingredient of the Year: Microbiome Modulation" at the prestigious NutraIngredients-USA Awards, hosted by William Reed."We're honored to be recognized alongside industry leaders through such a well-respected awards process," said Shaheen Majeed, Sabinsa's Global CEO....

Read more

AlzeCure Pharma to Present at Stora Aktiedagarna in Stockholm on June 10

June 3, 2025 4:20 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company's CEO Martin Jönsson will present at Stora Aktiedagarna in Stockholm, Sweden, hosted by Aktiespararna, at 08:50 CET on June 10.In his presentation, Martin Jönsson will highlight the company's project portfolio and drug candidates...

Read more

Spago Nanomedical Continues Patient Recruitment in the Phase I/IIa Study Tumorad-01 as Planned after DMC Recommendation

June 3, 2025 2:20 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - Spago Nanomedical AB (publ) announced today that the Data Monitoring Committee (DMC) recommends the ongoing phase I/IIa study Tumorad-01 with the candidate drug 177 Lu-SN201 to continue according to the current study protocol with the recruitment of additional two patients at the current highest dose. The recommendation is based on the analysis of data from all three patient cohorts totaling 10 dosed...

Read more

Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests

June 3, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc is pleased to announce that the second patient has been successfully treated in the ongoing Phase I clinical trial of HG-CT-1, the Company's proprietary Chimeric Antigen Receptor T-cell (CAR-T) therapy for relapsed/refractory acute myeloid leukemia (R/R AML) in adults.The treatment was well tolerated and met the trial's predefined initial safety criteria. Encouragingly, early indications of clinical efficacy are...

Read more

Notice To Convene Extraordinary General Meeting Regarding Extraordinary Dividend

June 3, 2025 1:50 AM

Gubra (CPH:GUBRA)Notice to convene extraordinary GENERAL MEETING REGARDING EXTRAORDINARY DIVIDENDGUBRA A/SCVR NO. 30 51 40 41To the shareholders of Gubra A/S (CVR no. 30 51 40 41), notice is hereby given to convene an extraordinary general meeting of Gubra A/S (the " Company " or " Gubra ") to be held on:Friday 27 June2025 AT 12:00 AM (CEST)GUBRA A/SHØRSHOLM KONGEVEJ 11BDK-2970 HØRSHOLMGiven the limited agenda, shareholders are encouraged to...

Read more

Concierge Doctor in Los Angeles: Dr. Feliciano Serrano Redefines Varicose Vein Treatment Through Concierge Medicine

June 2, 2025 7:45 PM

Traditionally, treating varicose veins often required a series of tedious clinic visits, long wait times, and a one-size-fits-all approach. For many, it was not only daunting but also a process that felt impersonal. That was until Dr. Feliciano Serrano, a pioneer in concierge medicine, brought an innovative and compassionate approach to varicose vein care right to the heart of Los Angeles.With an impressive track record and a dedication to...

Read more

18 Complete Care Facilities Recognized With 2025 AHCA/NCAL Bronze Quality Award

June 2, 2025 5:00 PM

Complete Care Management is proud to announce that 18 of its skilled nursing and post-acute care facilities have been honored with the 2025 Bronze - Commitment to Quality Award by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL). This prestigious national recognition affirms each facility's dedication to improving the lives of residents through consistent, person-centered care and performance...

Read more

Mann Eye Institute Announces Relocation of the Woodlands Office to State-of-the-Art New Facility

June 2, 2025 4:05 PM

Mann Eye Institute, Texas's premier vision correction and eye care provider, is announcing the relocation of its Woodlands office to a new, enhanced facility. Effective June 2, 2025, the practice will move from its current location at 1501 Lake Robbins Dr., Suite 130, to 17450 St. Luke's Way, Suite 100, in The Woodlands.The new location will feature expanded capabilities while maintaining the same exceptional level of care that has made Mann Eye...

Read more

NOTICE OF extraordinary GENERAL MEETING in Senzime AB (PUBL)

June 2, 2025 1:50 PM

Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby to an extraordinary general meeting on 30 June 2025 at 15.00 at the Compnay's premises on Verkstadsgatan 8, house 1, Uppsala.Notice etc.Shareholders who wish to participate in the general meeting must:be registered in the share register kept by Euroclear Sweden AB on Thursday 29 June 2025 (the record date), andnotify his...

Read more

Black Book Research: Health Plans Double Down on AI-Powered Fraud and Claims Integrity Solutions Amid Rising Audit Pressures

June 2, 2025 11:15 AM

As healthcare payers confront a convergence of regulatory scrutiny, rising cost pressures, and increasingly sophisticated fraud schemes, the demand for advanced claims integrity solutions has reached a critical inflection point. In 2024 alone, the Centers for Medicare & Medicaid Services (CMS) flagged more than $1.9 billion in Medicare Advantage overpayments, while improper payments across Medicare and Medicaid programs surpassed $100 billion....

Read more

Wellnee Pain Relief Patches Reviews [Urgent Update]: Don't Buy Until You Read This

June 2, 2025 11:10 AM

If you've been battling chronic knee pain, you know how frustrating the search for real relief can be. Pills come with side effects. Injections aren't exactly fun. And those sticky creams? Messy and short-lived. That's where Wellnee claims to change the game - a simple patch you apply to your skin, offering targeted pain relief without drugs, needles, or greasy residue. Promoted as a non-invasive, herbal alternative to conventional painkillers,...

Read more

HonorBridge Celebrates 40 Years With Fifth Straight Best Employer Win

June 2, 2025 10:00 AM

HonorBridge, North Carolina's largest organ donation and tissue recovery organization, is proud to announce it has been named a 2025 Best Employer in North Carolina by Business North Carolina Magazine, marking its fifth consecutive year receiving this recognition. The honor comes during a landmark year as HonorBridge celebrates its 40th anniversary of saving and healing lives across the state. With offices in Chapel Hill, Winston-Salem, and...

Read more

1933 Industries Announces the Completion of the Purchase of 9% Interest of Cultivation and Production Subsidiary

June 2, 2025 9:00 AM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce the completion of the amended Membership Interest Purchase Agreement (the "MIPA") entered into by its wholly owned subsidiary, FN Pharmaceuticals, and Mr. Caleb Zobrist (the "Seller") to acquire his nine percent (9%) of the issued and outstanding membership interests of Alternative...

Read more

Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform

June 2, 2025 8:30 AM

Telomir Pharmaceuticals, Inc. (Nasdaq:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced its participation in the BIO International Convention 2025, taking place in Boston, MA from June 16-19, 2025. The Company has scheduled a full week of BIO One-on-One Partnering™ meetings to explore strategic collaborations, licensing opportunities, and potential M&A transactions.Telomir is actively preparing to...

Read more